Criteria
Leader criteria
Sector
Communication Services
80
Consumer Discretionary
292
Consumer Staples
106
Energy
122
Financials
467
Health Care
446
Industrials
477
Information Technology
431
Materials
223
Real Estate
119
Utilities
77
Russell 3000. FTSE Russell does not publish this list, so it is reconstructed here as the 3,000 largest US operating companies by market value. It will not match the published index name for name.
Russell 3000
| Ticker ▲ | Company | Index | Sector | Price | 1wk | 1mo | 1yr | ATR% | RS | Trend | Market cap | P/E | PEG | ROE | P/B | D/E | EPS growth | F-score | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DFTX | Definium Therapeutics, Inc. | Health Care | $36.33 | up 1.9% | down 4.5% | up 171.3% | 5.0% | 96 | 6/8 | $3.6B | — | — | down 64% | 10.8× | 0.12 | — | — | Unknown | |
| DGX | Quest Diagnostics Inc | Health Care | $251.82 | up 4.1% | up 8.4% | up 45.2% | 2.5% | 82 | 8/8 | $40.8B | 41.1× | 2.96 | up 14% | 5.7× | 0.72 | up 28% | 6/9 | Low | |
| DMRA | Damora Therapeutics, Inc. | Health Care | $21.49 | up 1.9% | up 1.0% | up 192.4% | 7.1% | 78 | 2/8 | $34.3M | — | — | down 164% | 0.1× | — | — | — | Unknown | |
| DNA | Ginkgo Bioworks Holdings, Inc. | Health Care | $11.21 | up 12.2% | down 12.6% | down 6.7% | 11.8% | 73 | 7/8 | $652.5M | — | — | 0% | 1.3× | — | — | — | Elevated | |
| DNLI | Denali Therapeutics Inc. | Health Care | $18.94 | up 2.9% | down 8.4% | up 15.6% | 4.1% | 33 | 3/8 | $3.0B | — | — | down 46% | 2.9× | — | — | — | Low | |
| DNTH | Dianthus Therapeutics, Inc. /De/ | Health Care | $82.38 | up 7.3% | down 6.4% | up 144.2% | 4.8% | 85 | 4/8 | $3.6B | — | — | down 38% | 7.2× | — | — | — | Low | |
| DRTS | Alpha Tau Medical Ltd. | Health Care | $13.06 | down 0.8% | down 12.4% | up 223.3% | 4.8% | 97 | 7/8 | $1.1B | — | — | down 61% | 14.9× | 0.08 | — | — | Unknown | |
| DRUG | Bright Minds Biosciences Inc. | Health Care | $54.98 | up 4.8% | up 10.4% | up 0.9% | 6.4% | 13 | 0/8 | — | — | — | — | — | — | — | — | Unknown | |
| DSGN | Design Therapeutics, Inc. | Health Care | $10.68 | up 4.3% | down 15.0% | up 63.6% | 6.2% | 50 | 3/8 | $645.1M | — | — | down 31% | 3.0× | — | — | — | Low | |
| DVA | Davita Inc. | Health Care | $187.50 | up 2.1% | up 7.2% | up 57.9% | 3.9% | 78 | 6/8 | $12.9B | 11.9× | — | — | — | — | up 67% | — | Elevated | |
| DXCM | Dexcom Inc | Health Care | $82.29 | up 5.6% | down 4.6% | up 20.7% | 3.2% | 65 | 6/8 | $31.7B | 37.9× | 0.79 | up 34% | 11.5× | — | up 3% | 8/9 | Low | |
| DYN | Dyne Therapeutics, Inc. | Health Care | $16.69 | up 6.9% | up 3.6% | down 29.1% | 5.5% | 14 | 1/8 | $2.8B | — | — | 0% | 2.8× | 0.15 | — | — | Unknown | |
| EDIT | Editas Medicine, Inc. | Health Care | $2.67 | up 11.2% | up 3.9% | down 11.3% | 7.9% | 49 | 3/8 | $261.3M | — | — | down 198% | 9.6× | 1.96 | — | — | Elevated | |
| EHC | Encompass Health Corp | Health Care | $135.90 | up 9.5% | up 12.1% | up 17.0% | 2.9% | 81 | 8/8 | $15.8B | 27.9× | 1.15 | up 25% | 6.5× | 1.02 | up 11% | — | Moderate | |
| ELAN | Elanco Animal Health Inc | Health Care | $23.06 | up 2.4% | up 3.0% | up 2.2% | 2.9% | 35 | 1/8 | $11.5B | — | — | down 4% | 1.8× | 0.61 | up 385% | 4/9 | Elevated | |
| ELV | Elevance Health, Inc. | Health Care | $420.07 | down 4.5% | up 8.0% | up 32.5% | 2.8% | 73 | 8/8 | $92.7B | 16.4× | — | up 13% | 2.1× | 0.70 | up 18% | 7/9 | Low | |
| ELVN | Enliven Therapeutics, Inc. | Health Care | $44.25 | up 6.6% | down 3.5% | up 84.6% | 4.2% | 80 | 5/8 | $2.6B | — | — | down 27% | 5.7× | — | — | — | Unknown | |
| ENOV | Enovis Corp | Health Care | $19.91 | down 5.6% | up 9.0% | down 35.1% | 5.4% | 10 | 0/8 | $1.1B | — | — | down 58% | 0.8× | 0.85 | — | 5/9 | Elevated | |
| ENSG | Ensign Group, Inc | Health Care | $181.52 | up 3.4% | up 5.5% | up 0.8% | 2.9% | 47 | 2/8 | $10.5B | 30.7× | 2.16 | up 17% | 4.7× | 0.06 | up 24% | 6/9 | Low | |
| ENTX | Entera Bio Ltd. | Health Care | $3.20 | up 9.6% | up 10.0% | up 13.5% | 6.8% | 96 | 8/8 | $147.8M | — | — | down 108% | 11.3× | — | — | 2/9 | Low | |
| EOLS | Evolus, Inc. | Health Care | $7.35 | up 4.9% | down 8.1% | up 9.4% | 4.9% | 84 | 7/8 | $477.8M | — | — | — | — | — | — | 3/9 | Elevated | |
| EPRX | Eupraxia Pharmaceuticals Inc. | Health Care | $6.83 | down 0.6% | down 24.9% | up 28.1% | 7.7% | 45 | 2/8 | $354.7M | — | — | down 67% | 4.3× | 0.00 | — | — | Low | |
| ERAS | Erasca, Inc. | Health Care | $14.35 | down 0.3% | down 2.1% | up 483.3% | 6.8% | 99 | 4/8 | $4.1B | — | — | down 33% | 12.5× | — | — | — | Unknown | |
| ESTA | Establishment Labs Holdings Inc. | Health Care | $62.46 | down 2.1% | down 2.7% | up 22.7% | 6.1% | 23 | 2/8 | $1.8B | — | — | down 133% | 77.7× | 10.51 | — | 4/9 | Moderate | |
| ETON | Eton Pharmaceuticals, Inc. | Health Care | $52.18 | up 4.4% | up 1.3% | up 185.9% | 4.9% | 99 | 7/8 | $1.4B | — | — | down 18% | 54.0× | 0.83 | — | 4/9 | Low |